AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $311,000 | +31.2% | 23,006 | +86.9% | 0.08% | +143.8% |
| Q3 2019 | $237,000 | -66.9% | 12,309 | -49.2% | 0.03% | -60.0% |
| Q2 2019 | $715,000 | +93.8% | 24,209 | +303.5% | 0.08% | +300.0% |
| Q3 2018 | $369,000 | -62.3% | 6,000 | -63.4% | 0.02% | -66.7% |
| Q4 2017 | $980,000 | +213.1% | 16,400 | +154.5% | 0.06% | +185.7% |
| Q3 2017 | $313,000 | +21.3% | 6,444 | +31.3% | 0.02% | +23.5% |
| Q2 2017 | $258,000 | +17.8% | 4,906 | -60.6% | 0.02% | +41.7% |
| Q2 2016 | $219,000 | -70.1% | 12,437 | -69.8% | 0.01% | -66.7% |
| Q3 2015 | $732,000 | – | 41,248 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |